Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,113,186
  • Shares Outstanding, K 236,390
  • Annual Sales, $ 258,220 K
  • Annual Income, $ -28,240 K
  • EBIT $ 115 M
  • EBITDA $ 126 M
  • 60-Month Beta 0.70
  • Price/Sales 16.39
  • Price/Cash Flow 352.24
  • Price/Book 18.25

Options Overview Details

View History
  • Implied Volatility 64.09% ( -1.73%)
  • Historical Volatility 64.99%
  • IV Percentile 52%
  • IV Rank 28.76%
  • IV High 171.68% on 04/05/24
  • IV Low 20.64% on 02/13/24
  • Put/Call Vol Ratio 0.42
  • Today's Volume 2,272
  • Volume Avg (30-Day) 2,768
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 65,743
  • Open Int (30-Day) 56,009

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.17
  • Number of Estimates 2
  • High Estimate 0.19
  • Low Estimate 0.15
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +325.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.08 +1.87%
on 12/20/24
22.19 -21.59%
on 11/27/24
-3.97 (-18.58%)
since 11/20/24
3-Month
15.33 +13.50%
on 10/21/24
23.64 -26.40%
on 11/11/24
-2.58 (-12.91%)
since 09/20/24
52-Week
4.07 +327.52%
on 12/21/23
23.64 -26.40%
on 11/11/24
+13.31 (+325.43%)
since 12/20/23

Most Recent Stories

More News
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA : 17.40 (-2.79%)
Insider Sale: CFO and Treasurer of $ADMA (ADMA) Sells 15,000 Shares

Brad L. Tade, the CFO and Treasurer of $ADMA ($ADMA), sold 15,000 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.0% of their...

ADMA : 17.40 (-2.79%)
Adma Biologics: Q3 Earnings Snapshot

Adma Biologics: Q3 Earnings Snapshot

ADMA : 17.40 (-2.79%)
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

ADMA : 17.40 (-2.79%)
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

ADMA : 17.40 (-2.79%)
Adma Biologics: Q2 Earnings Snapshot

Adma Biologics: Q2 Earnings Snapshot

ADMA : 17.40 (-2.79%)
Adma Biologics: Q1 Earnings Snapshot

Adma Biologics: Q1 Earnings Snapshot

ADMA : 17.40 (-2.79%)
Chart of the Day: ADMA Biologics - Hitting New Highs

The Chart of the Day belongs to the biomedical company ADMA Biologics (ADMA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

ADMA : 17.40 (-2.79%)
Adma Biologics: Q4 Earnings Snapshot

Adma Biologics: Q4 Earnings Snapshot

ADMA : 17.40 (-2.79%)
Why Adma Biologics Stock Crushed the Market on Friday

The network of FDA-approved collection facilities continues to grow.

ADMA : 17.40 (-2.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying...

See More

Key Turning Points

3rd Resistance Point 18.76
2nd Resistance Point 18.36
1st Resistance Point 17.88
Last Price 17.40
1st Support Level 17.00
2nd Support Level 16.60
3rd Support Level 16.12

See More

52-Week High 23.64
Last Price 17.40
Fibonacci 61.8% 16.16
Fibonacci 50% 13.85
Fibonacci 38.2% 11.55
52-Week Low 4.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar